Apoptosis induction effects of EGCG in laryngeal squamous cell carcinoma cells through telomerase repression

Archives of Pharmacal Research

Volumn 32, Issue 9, 2009, Pages 1263-1269

  Wang, Xi ^a   Hao, Miao Wang ^a   Dong, Ke ^a   Lin, Fang ^a   Ren, Ji Hong ^a   Zhang, Hui Zhong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; EGCG; HTERT; Telomerase

Indexed keywords

CASPASE 3; DNA; EPIGALLOCATECHIN GALLATE; MESSENGER RNA; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER PREVENTION; CELL CYCLE ARREST; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA CONTENT; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REPRESSION; FLOW CYTOMETRY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; LARYNX CARCINOMA; SQUAMOUS CELL CARCINOMA; TEA; TELOMERE; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CATECHIN; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME ACTIVATION; G1 PHASE; HUMANS; LARYNGEAL NEOPLASMS; TELOMERASE;

EID: 70349558298     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-009-1912-8     Document Type: Article

References (30)

1. N. Ahmad D. K. Feyes A. L. Nieminen R. Agarwal H. Mukhtar 1997 Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrestin human carcinoma cells J. Natl. Cancer Inst. 89 1881 1886 9414176 10.1093/jnci/89.24.1881 1:CAS:528:DyaK1cXhvFKrsA%3D%3D
2. N. Ahmad P. Cheng H. Mukhtar 2000 Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate Biochem. Biophys. Res. Commun. 275 328 324 10964666 10.1006/bbrc.2000.3297 1:CAS:528:DC%2BD3cXmtVGmsrg%3D (Pubitemid 30682879)
3. J. Bindewald J. Oeken D. Wollbrueck C. Wulke A. Dietz E. Herrmann R. Schwarz S. Singer 2007 Quality of life correlates after surgery for laryngeal carcinoma Laryngoscope 117 1770 1776 17906497 10.1097/MLG.0b013e3180caa18c (Pubitemid 47508708)
4. E. H. Blackburn 2000 Telomere states and cell fates Nature 408 53 56 11081503 10.1038/35040500 1:CAS:528:DC%2BD3cXotValu7Y%3D (Pubitemid 30828255)
5. P. De Souza Nascimento G. Alves W. Fiedler 2006 Telomerase inhibition by an siRNA directed against hTERT leads to telomere attrition in HT29 cells Oncol. Rep. 16 423 428 16820926
6. H. Fujiki M. Suganuma S. Matsuyama K. Miyazaki 2005 Cancer prevention with green tea polyphenols for the general populations and for patients following cancer treatment Curr. Cancer Ther. Rev. 1 109 114 10.2174/1573394052952474 1:CAS:528:DC%2BD2MXislOjurw%3D
7. C. B. Harley 2008 Telomerase and cancer therapeutics Nat. Rev. Cancer 8 167 179 18256617 10.1038/nrc2275 1:CAS:528:DC%2BD1cXitlOjuro%3D (Pubitemid 351305939)
8. A. K. Khaw M. Silasudjana B. Banerjee M. Suzuki R. Baskar M. P. Hande 2007 Inhibition of telomerase activity and human telomerase reverse transcriptase gene expression by histone deacetylase inhibitor in human brain cancer cells Mutat. Res. 625 134 144 17669439 1:CAS:528:DC%2BD2sXht1KrtbzE
9. N. W. Kim M. A. Piatyszek K. R. Prowse C. B. Harley M. D. West P. L. Ho G. M. Coviello W. E. Wright S. L. Weinrich J. W. S. Shay 1994 pecific association of human telomerase activity with immortal cells and cancer Science 266 2011 2015 7605428 10.1126/science.7605428 1:CAS:528:DyaK2MXisl2lu7g%3D
10. K. Kraemer S. Fuessel U. Schmidt M. Kotzsch B. Schwenzer M. P. Wirth A. Meye 2003 Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells Clin. Cancer Res. 9 3794 3800 14506173 1:CAS:528:DC%2BD3sXosVOks7s%3D
11. S. Kyo T. Kanaya M. Takakura M. Tanaka M. Inoue 1999 Human telomerase reverse transcriptase as a critical determinant of telomerase activity innormal and malignant endometrial tissues Int. J. Cancer 80 60 63 9935231 10.1002/(SICI)1097-0215(19990105)80:1<60::AID-IJC12>3.0.CO;2-E 1:CAS:528:DyaK1cXotVOntrc%3D
12. S. Lamy D. Gingras R. Beliveau 2002 Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation Cancer Res. 62 381 385 11809684 1:CAS:528:DC%2BD38XhtVyhsbc%3D
13. S. C. Lin W. C. Li J. W. Shih K. F. Hong Y. R. Pan J. J. Lin 2006 The tea polyphenols EGCG and EGC repress mRNA expression of human telomerase reverse transcriptase (hTERT) in carcinoma cells Cancer Lett. 236 80 88 15975707 10.1016/j.canlet.2005.05.003 1:CAS:528:DC%2BD28XjvVGgs7k%3D
14. H. Matsumoto T. Yamane 2000 Green tea and cancer prevention J. Women's Cancer 2 153 158
15. A. Mittal M. S. Pate R. C. Wylie T. O. Tollefsbol S. K. Katiyar 2004 EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis Int. J. Oncol. 24 703 710 14767556 1:CAS:528:DC%2BD2cXitFantb0%3D
16. T. Mosmann 1983 Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays J. Immunol. Methods 65 55 63 6606682 10.1016/0022-1759(83)90303-4 1:STN:280: DyaL2c%2FovFSmtw%3D%3D
17. H. Mukhtar N. Ahmad 2000 Tea polyphenols: prevention of cancer and optimizing health Am. J. Clin. Nut. 71 1698 1702S
18. I. Naasani F. Oh-Hashi T. Oh-Hara W. Y. Feng J. Johnston K. Chan T. Tsuruo 2003 Blocking telomerase by dietary polyphenols is a major mechanism for limiting the growth of human cancer cells in vitro and in vivo Cancer Res. 63 824 830 12591733 1:CAS:528:DC%2BD3sXht1GqsL4%3D
19. T. M. Nakamura T. R. Cech 1998 Reversing time: origin of telomerase Cell 92 587 590 9506510 10.1016/S0092-8674(00)81123-X 1:CAS:528:DyaK1cXhvVWqs7g%3D (Pubitemid 28141505)
20. M. A. Rafferty J. E. Fenton A. S. Jones 2001 The history, aetiology and epidemiology of laryngeal carcinoma Clin. Otolaryngol. Allied. Sci. 26 442 446 11843920 10.1046/j.1365-2273.2001.00507.x 1:STN:280:DC%2BD387htVGgsw%3D%3D (Pubitemid 34088245)
21. D. Sadava E. Whitlock S. E. Kane 2007 The green tea polyphenol, epigallocatechin-3-gallate inhibits telomerase and induces apoptosis in drug-resistant lung cancer cells Biochem. Biophys. Res. Commun. 360 233 237 17585882 10.1016/j.bbrc.2007.06.030 1:CAS:528:DC%2BD2sXntFamt70%3D (Pubitemid 46994711)
22. T. Sato G. Miyata 2000 The nutraceutical benefit: part I: Green tea Nutrition 16 315 317 10758375 10.1016/S0899-9007(99)00301-9 1:CAS:528: DC%2BD3cXitlOru70%3D (Pubitemid 30176066)
23. A. Scalbert I. T. Johnson M. Saltmarsh 2005 Polyphenols: antioxidants and beyond Am. J. Clin. Nutr. 81 215S 217S 15640483 1:CAS:528: DC%2BD2MXlvFKlsQ%3D%3D
24. M. Shimizu I. B. Weinstein 2005 Modulation of signal transduction by tea catechins and related phytochemicals Mutat. Res. 591 147 160 15992833 1:CAS:528:DC%2BD2MXht1Gnu7%2FP
25. Y. Tamura S. Tanaka R. Asato S. Hirano M. Yamashita H. Tamaki J. Ito 2007 Therapeutic outcomes of laryngeal cancer at Kyoto University Hospital for 10 years Acta. Otolaryngol. Suppl. 557 62 65 17453448 10.1080/00016480601067990 (Pubitemid 46440548)
26. C. S. Yang Z. Y. Wang 1993 Tea and cancer J. Natl. Cancer Inst. 85 1038 1049 8515490 10.1093/jnci/85.13.1038 1:CAS:528:DyaK3sXmt1Cnu7g%3D
27. C. S. Yang P. Maliakal X. Meng 2002 Inhibition of carcinogenesis by tea Annu. Rev. Pharmacol. Toxicol. 42 25 54 11807163 10.1146/annurev.pharmtox.42. 082101.154309 1:CAS:528:DC%2BD38XhvFKnsLg%3D (Pubitemid 34160518)
28. H. Yu Y. F. Xin X. D. Duan L. X. Zhu D. J. Jin 2007 Dynamic analysis of epidemiology and etiology on laryngeal carcinoma Mod. Biomed. Progr. 3 393 395
29. S. M. Zeitels A. Blitzer R. E. Hillman R. R. Anderson 2007 Foresight in laryngology and laryngeal surgery: a 2020 vision Ann. Otol. Rhinol. Laryngol. Suppl. 198 2 16 17937068
30. Q. Zhang X. Tang Q. Lu Z. Zhang J. Rao A. D. G. Le 2006 reen tea extract and (-)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1á protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells Mol. Cancer Ther. 5 1227 1238 16731755 10.1158/1535-7163.MCT-05-0490 1:CAS:528:DC%2BD28XltVWnu7g%3D (Pubitemid 43881315)